AU Patent

AU2015200286B2 — Polymorphic forms st-246 and methods of preparation

Assigned to Siga Technologies Inc · Expires 2017-01-12 · 9y expired

What this patent protects

Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2 (1H)-yl) benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.

USPTO Abstract

Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2 (1H)-yl) benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number: AU2015200286B2
Jurisdiction: AU
Classification: —
Expires: 2017-01-12
Drug substance claim: No
Drug product claim: No
Assignee: Siga Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.